However, other lipoproteins may increase the risk of CAD and should be addressed, such as lipoprotein(a) (Lp(a)), a molecule bound to apolipoprotein(a) [5] with about one-fifth of the world's population (approximately 1.4 billion individuals) have high Lp(a) levels [5, 6]. Here, LPA is linked to coronary artery disorder.